Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |
mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0087 | 0.8 |
mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | 0.0079 | 0.8 |